10 people suffer food poisoning from Chinese-made 'gyoza'

10 people suffer food poisoning from Chinese-made 'gyoza'

TOKYO, Japan - Executives of Japan Tobacco Inc. and its subsidiary JT Foods Co. bow in apology during a press conference in Tokyo on Jan. 30 after reports that a total of 10 people have suffered food poisoning after eating Chinese-made frozen ''gyoza'' dumplings imported by JT Foods Co.

  • Product Code
  • ILEA001125969
  • Registered date
  • 2008/1/30 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2008 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 483.23(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Sompo CEO to step down over Bigmotor insurance fraud scandal

    TOKYO, Japan, Jan. 26 Kyodo - Major Japanese insurance firm Sompo Holdings Inc. CEO Kengo Sakurada holds a press conference in Tokyo on Jan. 26, 2024, to announce he will step down at the end of March to take responsibility for the company's involvement in used car dealer Bigmotor Co.'s insurance fraud scandal. (Kyodo)
      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
            Nomura information leaks

            Nomura information leaks

            Nomura Holdings Inc. CEO Koji Nagai (L) and Nomura Securities Co. President Toshio Morita (2nd from L) bow in apology at a press conference in Tokyo on May 24, 2019. Nomura admitted to information leaks at its core brokerage unit and its executives will take temporary pay cuts of up to 30 percent over the issue. (Kyodo) ==Kyodo
              Nomura information leaks

              Nomura information leaks

              Nomura Holdings Inc. CEO Koji Nagai (L) and Nomura Securities Co. President Toshio Morita bow in apology at a press conference in Tokyo on May 24, 2019. Nomura admitted to information leaks at its core brokerage unit and its executives will take temporary pay cuts of up to 30 percent over the issue. (Kyodo) ==Kyodo
                McDonald's Japan apologizes for new food-safety scandal

                McDonald's Japan apologizes for new food-safety scandal

                TOKYO, Japan - Takehiko Aoki (2nd from L), senior vice president of McDonald's Holdings Co. (Japan), and other officials bow at a press conference in Tokyo on Jan. 7, 2015, to apologize for the contamination of some food items at its restaurants.
                  Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

                  Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

                  TOKYO, Japan - Tatsuo Higuchi, president of Otsuka Holdings Co., attends a press conference in Tokyo's Minato Ward on Dec. 2, 2014, on the planned acquisition by its subsidiary Otsuka Pharmaceutical Co. of California-based biopharmaceutical firm Avanir Pharmaceuticals Inc. for $3.54 billion through a tender offer to be followed by a merger. The Japanese nutrition product and drug manufacturer will pay $17 per Avanir share in the takeover bid through its U.S. subsidiary.
                    Aeon to fully own Daiei

                    Aeon to fully own Daiei

                    TOKYO, Japan - Motoya Okada, president of Japan's biggest retailer Aeon Co., tells a press conference in Tokyo on Sept. 24, 2014, it will buy the remaining shares in Daiei Inc. to make the struggling supermarket chain a wholly owned subsidiary as part of efforts to turn around the company.
                      Ajinomoto to buy U.S. frozen foods maker Windsor

                      Ajinomoto to buy U.S. frozen foods maker Windsor

                      TOKYO, Japan - Masatoshi Ito (R), president of Ajinomoto Co., and Greg Geib, president of Windsor Quality Holdings, shake hands during a press conference in Tokyo on Sept. 10, 2014. They announced that Japan's Ajinomoto will buy the U.S. frozen foods maker for about $800 million in a bid to grow its presence in the giant North American market.